Navigation Links
Massachusetts Motrin Victim Set to Receive more than $100 Million from Recent Lawsuit – Kiley Law Group, LLC
Date:3/10/2013

Boston, Massachusetts (PRWEB) March 10, 2013

According to Boston.com, a Massachusetts teenager and her parents should receive more than $100 million, including interest, from Johnson and Johnson and its McNeil-PPC Inc. subsidiary. A Plymouth Superior Court (Case number: PLCV2007-00064) jury ruled in favor of Samantha, a 7-year-old at her time of injury, who suffered a life-threatening drug reaction which resulted in the loss of most of her skin.

According to Brad Henry, Samantha's attorney, Samantha battled toxic epidermal necrolysis, a rare side effect that was attributed to her use of Motrin, which led to blindness, brain damage, and irreparable damage to 90 percent of her skin,. Searing her respiratory system, the disease has left her scarred inside and out. She is still unable to utilize 80 percent of her lung capacity.

Tom Kiley Sr., Personal Injury Lawyer, has represented countless Massachusetts injury victims. According to Tom, products that result in catastrophic injuries and deaths are more common than most would like to believe.

“Defective products resulting from improper labeling or haphazard manufacturing have contributed to countless injuries and deaths. In cases such as Samantha’s, the medical expenses and pain and suffering that resulted cannot be compensated. From the age of seven until well into her teenage years, she has had to endure a level of pain that few of us will ever have to experience and the treatment that she needs will most likely last several years into her future.”

“When manufacturers produce products, they have a responsibility to make them relatively safe for the public to use. When they fail to do so, those who have suffered as a result have the right to pursue compensation for their injuries. We take pride in providing our clients with legal representation that they can rely on, because when you enter the courtroom with multi-million dollar corporations, you need defect lawyers who have the will and the means to obtain justice at any cost,” said attorney Kiley.

The jury awarded $6.5 million to each of Samantha’s parents and $50 million in compensation to Samantha herself. The McNeil unit, Johnson & Johnson’s subsidiary, did not agree with the verdict and may pursue additional legal options.

“The Reckis family has suffered a tragedy, and we sympathize deeply with them. A number of medicines, including ibuprofen, have been associated with allergic reactions and as noted on the label, consumers should stop using medications and immediately contact a healthcare professional if they have an allergic reaction, it said in a statement.

About Kiley Law Group, LLC

Kiley Law Group, LLC is a defective product law firm based in Andover, Massachusetts. Their attorneys assist those who suffered injuries as a result of defective medications and devices.
They provide free professional case evaluations with no obligation to retain their services for those who have used vaginal mesh products, defective drugs, auto defects, and more.

For more information about their firm call 888-208-1695 to speak with an experienced product liability attorney today.

Read the full story at http://www.prweb.com/releases/motrin/lawsuit/prweb10507071.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Study finds Massachusetts health reform leads to increased inpatient surgical procedures
2. In Massachusetts, individual mandate led to decreased hospital productivity
3. Second Compounding Pharmacy Shut Down in Massachusetts
4. Marketing Xocolate International Corporation; Xocai, Announces Their 12-Week Weight Loss Challenge To Make Healthy Changes
5. Xocai Maryland
6. Xocai Massachusetts
7. High Fat Diet Tied to Increased Diabetes Risk Nature according to University of Massachusetts study reviewed by Naturecast Products
8. Massachusetts' Deval Patrick Wins "Green Governor of the Year Award" -- First State to Win Federal Approval for Offshore Wind Farms says BE
9. Massachusetts Medical Marijuana Caregivers Wanted To Partner With Compassionate Caregivers Of Massachusetts
10. Cost of Snakebite Therapy May Squeeze Victims Wallets
11. Car crash victims more likely to survive if taken directly to a trauma centre
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2017)... Austin, TX (PRWEB) , ... July 27, 2017 ... ... has been selected as a finalist in this year’s Fierce Innovation Awards: Healthcare ... recognized as a finalist in the category of Population Health Management/Patient Engagement Solutions. ...
(Date:7/26/2017)... ... ... An inventor from Salisbury, N.C., knows the difficulties involved with leech therapy. "I ... to keep leeches in place during therapy," she said. "That’s why I came up ... to keep a leech in place on the skin during therapy. It prevents the ...
(Date:7/26/2017)... Ca (PRWEB) , ... July 26, 2017 , ... A ... lyophilization processes. Inconsistent results freeze drying samples and a lengthy freeze dry cycle are ... webinar will discuss freeze drying techniques, as well as new accessories and advancements in ...
(Date:7/26/2017)... 92660 (PRWEB) , ... July 26, 2017 , ... ... for on-premises, off and in the cloud ; today announced the availability of ... algorithms within a simple to use control console for Data Discovery, Classification, Encryption ...
(Date:7/26/2017)... ... July 26, 2017 , ... Isodiol International Inc. ... innovator, specializing in the development of pharmaceutical and consumer products, announces the operational ... June 30, 2017. Iso International LLC recorded unaudited fiscal Q1 profits of $897,596 ...
Breaking Medicine News(10 mins):
(Date:7/27/2017)... EXTON, Pa., July 27, 2017  West Pharmaceutical Services, ... financial results for the second-quarter 2017 and updated financial ... Second-Quarter 2017 Highlights Reported ... 2.5% over the prior-year quarter. Net sales at constant ... 2017 reported-diluted EPS was $0.51, compared to $0.60 in ...
(Date:7/25/2017)... BARCELONA, Spain and CAMBRIDGE, Massachusetts ... SOM Biotech, specializing in repurposing drugs to treat rare nervous ... Therapeutics Inc. to clinically develop and market the drug SOM0226 ... reached, the drug achieved very promising results in a Phase ... A new office in the United ...
(Date:7/21/2017)... RESEARCH TRIANGLE PARK, N.C. , July 21, 2017 ... ) announced today that it will report its second ... Thursday, July 27, 2017. ... July 27, 2017, at 9:00 a.m. Eastern Time.  The ... dialing 1-970-315-0533.  A rebroadcast of the teleconference will be ...
Breaking Medicine Technology: